FDA Warns of Possible False Results From Some COVID-19 Tests

The U.S. Food and Drug Administration (FDA) on March 1 said that three rapid COVID-19 tests shouldn’t be used because of the potential for producing false results.

The FDA told people to avoid using the Celltrion DiaTrust COVID-19 Ag Rapid Test, the SD Biosensor Inc. STANDARD Q COVID-19 Ag Home Test, and the Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing).

“The FDA is concerned about the risk of false results when using” those tests, according to the agency. These tests have “not been authorized, cleared or approved by the FDA for distribution or use in the United States,” the agency said.